CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
The Hearing Laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00787189
NCT00787189N/ACompleted

The Effects of the Erchonia Hearing Laser on Word Recognition in Hearing Impaired Individuals Clinical Study Protocol

Erchonia Corporation·interventional·Posted Nov 7, 2008·Updated May 28, 2021

In Brief

A clinical study evaluating The Hearing Laser and Placebo Laser for Sensorineural Hearing Loss. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The purpose of this clinical study is to determine the effectiveness of low level laser light therapy when applied around the head and ears in improving unaided word recognition in ears with sensorineural hearing loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 7, 2008
Enrollment StartAug 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.7 years ago

Interventions

The Hearing Laserdevice

Two 6-minute low level laser light applications to the head/neck/ears region, each one week apart.

Placebo Laserdevice

inactive low level laser light therapy with no therapeutic output